Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

S&P Pharmaceuticals SPDR (NY: XPH )

49.26 USD +0.94 (+1.95%)
Official Closing Price Updated: 4:10 PM EDT, Apr 21, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about S&P Pharmaceuticals SPDR

< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
3 Pharmaceutical ETFs That Could Be Due For A Rebound
Here are three pharmaceutical ETFs have dropped to support, which means they may be about to rebound. 
Tags Pharma/Biotech ETFs Market News
From Blogs - TalkMarkets
3 Pharmaceutical ETFs That Could Be Due For A Rebound
These three pharmaceutical ETFs have dropped to support, which means they may be about to rebound. Support is a large concentration ... 
Tags XPH PILL Long Ideas
From Benzinga
Sum Up The Parts: XPH Could Be Worth $67
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Beyond COVID, Regeneron Is Betting Big on Oncology
Future growth will depend on its new checkpoint inhibitor wrangling market share away from Merck's Keytruda. 
Tags Market News XPH RHHBY
From Motley Fool
The Math Shows XPH Can Go To $68
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Implied XPH Analyst Target Price: $68
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Large Cap Biopharma Stalled With Move to Small Caps and Reflation Trade
Defensive large-cap biopharma stocks stalled as traders moved out on the risk curve seeking faster gains. 
Tags Stocks / Equities ETFs Healthcare
From Blogs - TalkMarkets
Pharma ETFs in Focus Post Q4 Earnings
The slew of Q4 results has led to mixed trading in pharma ETFs over the past 10 days. Here is a highlight of those in detail. 
Tags ETFs Healthcare
From Blogs - TalkMarkets
Sum Up The Pieces: XPH Could Be Worth $67
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Analysts Anticipate XPH Will Reach $67
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Analysts See 28% Upside For The Holdings of XPH
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
How The Pieces Add Up: XPH Headed For $65
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Big Pharma In Canada Offers C$1B In Last Attempt To Stop Drug Pricing Crackdown
The pharmaceutical industry has delivered aC$1 billion ($761 million) proposal to the Canadian government in an attempt to stave ... 
Tags Market News pharmaceuticals Canada
From Benzinga
Analysts Anticipate XPH To Hit $62
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
How The Parts Add Up: XPH Targets $60
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
A Low-Cost Pharma Fund for Drug Sector Exposure
The SPDR S&P Pharmaceuticals ETF (XPH) tracks an equal-weighted index of U.S. pharmaceutical companies. The exchange-traded fund seeks to provide exposure to the pharmaceuticals segment of the S&P... 
Tags Pharma/Biotech Stocks / Equities ETFs
From Blogs - TalkMarkets
2 Forever Pharma Stocks to Buy Now
Only one of these stocks has performed well this year, but both are worth buying and holding over the long term. 
Tags NVO XPH MRK
From Motley Fool
Look Under The Hood: XPH Has 29% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
3 Reasons to Buy Eli Lilly Stock
Eli Lilly has been outperforming — and could continue to outperform — the market. 
Tags Market News XPH LLY
From Motley Fool
Expect Pharma M&A to Rebound After COVID-19 Eases
The pharmaceutical industry is often a hotbed of takeover rumors. Some experts believe that speculation and deals themselves could heat up again after the coronavirus outbreak subsides, potentially... 
From ETFdb
Expect Pharmaceuticals M&A Activity to Rebound After COVID-19 Eases
The pharmaceutical industry is often a hotbed of takeover rumors. Some experts believe that speculation and deals themselves could heat up again after the coronavirus outbreak subsides, potentially... 
Tags PPH Pharmaceuticals tactical allocation channel
From ETF Trends
Pharma ETFs Gain On Healthy Q4 Earnings
Strong results led to solid trading in pharma ETFs over the past week. Here they are in detail. 
Tags ETFs
From Blogs - TalkMarkets
Could A More Significant Volatility Breakout Be Underway?
In a market that has been steadily climbing despite impeachment proceedings against President Trump, a roller-coaster ride due to tariffs and a trade war with China, and generalized global uncertainty,... 
Tags GLD / SPDR Gold Shares ETF XPH Powershares QQQ
From ETF Trends
A Look at the S&P Sectors from 2019
By Canterbury Investment Management Market State 1 (Bullish) – The S&P 500 continues its run in Market State 1, now at 14 consecutive days. Many equity assets experienced a nice little move to end... 
Tags IHI ETF Strategist Channel XPH
From ETF Trends
How The Parts Add Up: XPH Headed For $54
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
XPH's Holdings Could Mean 17% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Best & Worst Monthly Performers: December 18 Edition
Here is a look at the 25 best and 25 worst ETFs from the past week. Traders can use this list to find prospective candidates that have deviated too far from their longer-term trends, thereby serving as... 
From ETFdb
Is Coiled Volatility Suggesting Big Stock Move?
Options bets suggest that traders may be a bit too unnerved about the risks facing the stock market heading into the end of the year. History suggests that such complacency could come back to bite... 
From ETFdb
Markets Bounce Back & Close Week Near Record Highs
U.S. markets closed near record highs for the week, with the Dow Jones Industrial Average up 1.1% week to date, and the S&P 500 and Nasdaq Composite gathering 0.6% and 0.8%, respectively, for the week.... 
From ETFdb
Could Coiled Volatility Suggest A Bigger Stock Move Is Coming?
Options bets suggest that traders may be a bit too unnerved about the risks facing the stock market heading into the end of the year. History suggests that such complacency could come back to bite... 
Tags Relative Value Channel GLDM LQD
From ETF Trends
< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.